NOVOMIX 30FLEXPEN 3ML

About

NovoMix 30 FlexPen 3ML contains biphasic insulin aspart, a modern insulin analogue with a dual-action profile, consisting of 30% soluble insulin aspart and 70% protamine-crystallised insulin aspart. This formulation is specifically designed to provide both rapid-acting and intermediate-acting insulin effects, making it suitable for patients requiring both mealtime and basal glucose control. It is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 10 years and above. The rapid-acting component helps to control postprandial glucose excursions, typically administered shortly before a meal, while the intermediate-acting component provides sustained glucose lowering throughout the day, addressing basal insulin needs. Administered via a convenient pre-filled pen, it aims to simplify the insulin regimen and improve adherence, contributing to better overall glycemic management and reduction in HbA1c levels, thereby mitigating the risk of long-term diabetic complications associated with uncontrolled blood sugar levels. Regular monitoring of blood glucose is crucial to optimize dosing.

Uses

• Treatment of Type 1 diabetes mellitus
• Treatment of Type 2 diabetes mellitus
• Glycemic control for mealtime and basal needs
• Management of postprandial glucose excursions

Directions For Use

Administer subcutaneously as directed by your physician, typically before meals. Rotate injection sites to prevent lipodystrophy.

Benefits

• Provides both rapid and intermediate insulin action
• Offers flexible dosing around meal times
• Helps achieve comprehensive glycemic control
• Reduces the number of daily injections
• Convenient pre-filled pen for ease of use
• Contributes to lower HbA1c levels

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy (fat tissue changes at injection site)
• Weight gain
• Allergic reactions (rash, itching, hives)
• Peripheral edema (swelling of extremities)
• Pruritus (itching)
• Rash
• Urticaria (hives)
• Vision changes (temporary)
• Peripheral neuropathy (nerve damage)
• Hypokalemia (low potassium levels)

Safety Measures

• Alcohol - Alcohol consumption can lower blood sugar and increase the risk of hypoglycemia. Use with caution and monitor blood glucose levels closely.
• Pregnancy - Consult a doctor. Insulin requirements may change significantly during pregnancy. Close monitoring and dose adjustments are essential.
• Breastfeeding - Generally considered safe, but monitor the infant for signs of hypoglycemia. Discuss with your healthcare provider.
• Liver - Use with caution in patients with liver impairment. Dose adjustments may be necessary due to altered insulin metabolism.
• Kidney - Use with caution in patients with kidney impairment. Dose adjustments may be necessary due to reduced insulin clearance.
• Lung - No specific direct impact on lung function. Always inform your doctor about any pre-existing lung conditions or respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.